ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,173,000 | +3.6% | 160,983 | 0.0% | 0.57% | +7.2% |
| Q4 2021 | $2,098,000 | +38.9% | 160,983 | 0.0% | 0.53% | +31.7% |
| Q3 2021 | $1,510,000 | -8.4% | 160,983 | 0.0% | 0.40% | +16.2% |
| Q2 2021 | $1,648,000 | -2.1% | 160,983 | +75.9% | 0.34% | -13.8% |
| Q1 2021 | $1,684,000 | +197.5% | 91,531 | +453.7% | 0.40% | +138.1% |
| Q4 2020 | $566,000 | – | 16,531 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $31,126,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $7,360,000 | 2.65% |
| Logos Global Management LP | 1,010,812 | $18,599,000 | 1.82% |
| S Squared Technology, LLC | 181,220 | $3,334,000 | 1.58% |
| Avidity Partners Management LP | 1,677,845 | $30,872,000 | 0.85% |
| Perceptive Advisors | 3,425,916 | $63,037,000 | 0.80% |
| RTW INVESTMENTS, LP | 2,652,553 | $48,807,000 | 0.76% |
| Sofinnova Investments, Inc. | 509,168 | $9,369,000 | 0.56% |
| HighVista Strategies LLC | 32,062 | $590,000 | 0.44% |
| DAFNA Capital Management LLC | 91,531 | $1,684,000 | 0.40% |